CapitolMarkets
John Boozman
John Boozman
RSenateSenator · Arkansas

Sold up to $15,000 of AbbVie (ABBV)

Trade dated Aug 22, 202521 days to disclose
ABBV since the sale
+6.8%
S&P 500, same window
+17.3%
ABBV trailed the S&P 500 by 10.5 points since the sale

Price move from the trade date's close to the most recent close. A sale is favorable when the stock fell after.

On the public record around this trade

Committee activity, sponsored or cosponsored bills, and floor votes in this sector within 90 days — alongside the trade and its disclosure. Dated public record; draw your own conclusions.

  1. Jul 24, 2025Legislation
    Pharmaceutical sector
  2. Aug 22, 2025Trade
    Sold up to $15,000 of ABBV
  3. Sep 12, 2025Disclosure
    Disclosed the trade
    Public filing
  4. Nov 6, 2025Legislation
    Pharmaceutical sector
  5. Nov 19, 2025Legislation
    Pharmaceutical sector
  6. Nov 20, 2025Legislation
    Pharmaceutical sector
Source: U.S. Senate (efdsearch.senate.gov)
Get an alert the moment John Boozman files the next one

Capitol Markets tracks every Member of Congress in plain English — the trade, the price move, the committee overlap, the source filing.